Oral Medications Used for Incontinence in Children*
Medication | Some Adverse Effects |
|---|---|
Voiding dysfunction in diurnal incontinence (bladder overactivity) | |
Confusion, dizziness, increased temperature, flushing, constipation, dry mouth | |
Constipation, flushing, dry mouth | |
Constipation, dry mouth, gastrointestinal effects, blurred vision | |
Constipation, dry mouth, gastrointestinal effects, blurred vision | |
Headache, gastrointestinal effects, nasopharyngitis, hypertension | |
Enuresis | |
Intranasal DDAVP is no longer recommended because of the risk of dilutional hyponatremia. | |
Rarely, death† Possible nervousness, personality change, disordered sleep, cardiac arrhythmias‡ Should be used only for therapy-resistant cases given risk–benefit profile | |
* These medications are mostly used as 2nd-line therapy. Treatment of the underlying disorder and behavioral therapy should be used first. | |
† Sudden death of unclear etiology has been reported. This medication is now rarely used. | |